• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSF2在膀胱癌发展过程中通过Akt/Mtor途径损害Nrf2信号传导。

CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer.

作者信息

Yu Xi, Li Shenglan, Ke Shuai, Ye Chenglin, Wang Qinghua, Wang Huaxin, Wang Lei

机构信息

Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.

Department of Radiography, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.

出版信息

J Cancer. 2024 Apr 19;15(11):3242-3253. doi: 10.7150/jca.94343. eCollection 2024.

DOI:10.7150/jca.94343
PMID:38817867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11134447/
Abstract

Bladder Cancer (BCa) is one of the most common cancers of the urinary system. Colony-stimulating factor 2 (CSF2) is involved in many cancers, but not BCa. We investigated the effect of CSF2 on BCa in this study and the underlying molecular mechanisms. CSF2 mRNA levels in BCa were analyzed using the Cancer Genome Atlas (TCGA) database. Western blot was conducted to verify CSF2 expression in BCa tissue samples and cell lines. The effect of CSF2 on the growth of BCa cells was assessed by CCK8 and colony formation. To determine the migration and invasion capabilities of BCa cells, transwell analysis and wound healing assays were conducted. Next, western blot was used to explore the underlying mechanism. In the end, a xenografted BCa mouse model was established to examine the effects of CSF2 on tumorigenesis . Results showed that CSF2 mRNA was upregulated in BCa samples. Knocking down CSF2 significantly inhibited the proliferation and tumorigenesis of BCa cells and . Mechanism analysis revealed that CSF2 knockdown inhibited the proliferation and invasion of BCa cells via AKT/mTOR signaling. Based on these results, CSF2 promotes the proliferation and tumorigenesis of BCa.

摘要

膀胱癌(BCa)是泌尿系统最常见的癌症之一。集落刺激因子2(CSF2)与多种癌症有关,但与膀胱癌无关。在本研究中,我们调查了CSF2对膀胱癌的影响及其潜在的分子机制。使用癌症基因组图谱(TCGA)数据库分析膀胱癌中CSF2 mRNA水平。进行蛋白质免疫印迹法以验证CSF2在膀胱癌组织样本和细胞系中的表达。通过CCK8和集落形成评估CSF2对膀胱癌细胞生长的影响。为了确定膀胱癌细胞的迁移和侵袭能力,进行了Transwell分析和伤口愈合试验。接下来,使用蛋白质免疫印迹法探索潜在机制。最后,建立了异种移植膀胱癌小鼠模型以检查CSF2对肿瘤发生的影响。结果显示,CSF2 mRNA在膀胱癌样本中上调。敲低CSF2可显著抑制膀胱癌细胞的增殖和肿瘤发生。机制分析表明,敲低CSF2通过AKT/mTOR信号通路抑制膀胱癌细胞的增殖和侵袭。基于这些结果,CSF2促进膀胱癌的增殖和肿瘤发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/e19c5f7afda1/jcav15p3242g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/c8ac6b5248c7/jcav15p3242g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/a80a8f383cb7/jcav15p3242g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/a6eb92ffd3bc/jcav15p3242g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/1595dba694fb/jcav15p3242g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/971bbef230a2/jcav15p3242g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/eda8111c22cb/jcav15p3242g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/3040061ec7c3/jcav15p3242g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/e19c5f7afda1/jcav15p3242g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/c8ac6b5248c7/jcav15p3242g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/a80a8f383cb7/jcav15p3242g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/a6eb92ffd3bc/jcav15p3242g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/1595dba694fb/jcav15p3242g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/971bbef230a2/jcav15p3242g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/eda8111c22cb/jcav15p3242g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/3040061ec7c3/jcav15p3242g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c63d/11134447/e19c5f7afda1/jcav15p3242g008.jpg

相似文献

1
CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer.CSF2在膀胱癌发展过程中通过Akt/Mtor途径损害Nrf2信号传导。
J Cancer. 2024 Apr 19;15(11):3242-3253. doi: 10.7150/jca.94343. eCollection 2024.
2
HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor.HEATR3 参与膀胱癌的细胞增殖、转移和细胞周期发育,起到肿瘤抑制因子的作用。
Mol Genet Genomics. 2023 Nov;298(6):1353-1364. doi: 10.1007/s00438-023-02046-w. Epub 2023 Jul 31.
3
DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer.DHCR7 通过激活膀胱癌中的 PI3K/AKT/mTOR 信号通路促进肿瘤发生。
Cell Signal. 2023 Feb;102:110553. doi: 10.1016/j.cellsig.2022.110553. Epub 2022 Dec 5.
4
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.TEAD4 在膀胱癌中作为预后生物标志物,通过 PI3K/AKT 通路触发 EMT。
J Exp Clin Cancer Res. 2022 May 17;41(1):175. doi: 10.1186/s13046-022-02377-3.
5
HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.HYOU1通过PI3K/AKT/FOXO1反馈回路促进膀胱癌的细胞增殖、迁移和侵袭。
Mol Biol Rep. 2023 Jan;50(1):453-464. doi: 10.1007/s11033-022-07978-x. Epub 2022 Nov 8.
6
GREM1 is a potential biomarker for the progression and prognosis of bladder cancer.GREM1 是膀胱癌进展和预后的潜在生物标志物。
World J Surg Oncol. 2023 Aug 22;21(1):255. doi: 10.1186/s12957-023-03128-0.
7
ID2 Inhibits Bladder Cancer Progression and Metastasis PI3K/AKT Signaling Pathway.ID2通过PI3K/AKT信号通路抑制膀胱癌进展和转移。
Front Cell Dev Biol. 2021 Oct 22;9:738364. doi: 10.3389/fcell.2021.738364. eCollection 2021.
8
UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.UBE2T通过调节PI3K/AKT信号通路促进乳腺癌细胞的增殖、侵袭和糖酵解。
J Recept Signal Transduct Res. 2022 Apr;42(2):151-159. doi: 10.1080/10799893.2020.1870495. Epub 2021 Jan 12.
9
CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.环状 RNA HGS 通过调控 miR-513a-5p/VEGFC 轴并激活 AKT/mTOR 信号通路促进膀胱癌的进展。
Cell Cycle. 2023 Apr;22(8):919-938. doi: 10.1080/15384101.2022.2164454. Epub 2023 Jan 8.
10
Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway.角质蛋白 17 敲低抑制膀胱癌细胞的恶性程度和顺铂耐药性,并抑制 AKT 和 ERK 通路的激活。
Folia Histochem Cytobiol. 2021;59(1):40-48. doi: 10.5603/FHC.a2021.0005. Epub 2021 Feb 12.

引用本文的文献

1
Epitranscriptomic mechanisms and implications of RNA mC modification in cancer.癌症中RNA mC修饰的表观转录组学机制及其影响
Theranostics. 2025 Jul 25;15(16):8404-8428. doi: 10.7150/thno.112332. eCollection 2025.
2
CSF2 promotes chemoresistance in colorectal cancer by regulating Notch pathway.CSF2通过调节Notch信号通路促进结直肠癌的化疗耐药性。
Discov Oncol. 2025 Apr 9;16(1):495. doi: 10.1007/s12672-025-02285-w.
3
CircPRKCA facilitates esophageal squamous cell carcinoma metastasis via m5C-dependent CSF2 mRNA stabilization.

本文引用的文献

1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway.集落刺激因子 CSF2 通过调节 p-STAT3/MYC 通路介导小细胞肺癌的表型可塑性。
Oncol Rep. 2022 Jul;48(1). doi: 10.3892/or.2022.8333. Epub 2022 May 18.
3
Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation.
环状PRKCA通过m5C依赖的CSF2 mRNA稳定性促进食管鳞状细胞癌转移。
J Transl Med. 2025 Apr 1;23(1):385. doi: 10.1186/s12967-025-06395-5.
天然产物毛兰素通过NRF2失活诱导铁死亡来抑制膀胱癌细胞生长。
Front Pharmacol. 2021 Oct 29;12:775506. doi: 10.3389/fphar.2021.775506. eCollection 2021.
4
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).欧洲泌尿外科学会非肌层浸润性膀胱癌(Ta、T1和原位癌)指南
Eur Urol. 2022 Jan;81(1):75-94. doi: 10.1016/j.eururo.2021.08.010. Epub 2021 Sep 10.
5
Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.塔吉替宁C通过PERK-Nrf2-HO-1信号通路诱导大肠癌细胞发生铁死亡。
Int J Biol Sci. 2021 Jun 26;17(11):2703-2717. doi: 10.7150/ijbs.59404. eCollection 2021.
6
Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1.癌症治疗中巨噬细胞重编程的缺陷:PD-L1/PD-1 的负面影响。
Front Immunol. 2021 Jun 23;12:690869. doi: 10.3389/fimmu.2021.690869. eCollection 2021.
7
PSMD12 promotes glioma progression by upregulating the expression of Nrf2.PSMD12通过上调Nrf2的表达促进胶质瘤进展。
Ann Transl Med. 2021 Apr;9(8):700. doi: 10.21037/atm-21-1481.
8
Advances in bladder cancer biology and therapy.膀胱癌生物学和治疗的进展。
Nat Rev Cancer. 2021 Feb;21(2):104-121. doi: 10.1038/s41568-020-00313-1. Epub 2020 Dec 2.
9
Hesperetin Promotes Cisplatin-Induced Apoptosis of Gastric Cancer and by Upregulating Expression.橙皮素通过上调表达促进顺铂诱导的胃癌细胞凋亡。
Front Pharmacol. 2020 Aug 27;11:1326. doi: 10.3389/fphar.2020.01326. eCollection 2020.
10
DNER promotes epithelial-mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer.DNER 通过 Wnt/β-catenin 通路促进乳腺癌上皮-间质转化并阻止化疗敏感性。
Cell Death Dis. 2020 Aug 18;11(8):642. doi: 10.1038/s41419-020-02903-1.